Research outputs, reports, policy briefs and knowledge products from KIU scholars and partners.
Scholarly Work
Search peer-reviewed articles, reports, books, policy briefs and other scholarly outputs by KIU researchers and collaborators.
2025 | EURASIAN EXPERIMENT JOURNAL OF MEDICINE AND MEDICAL SCIENCES (EEJMMS) | Pp. 49-58
Cancer remains a leading global cause of morbidity and mortality, prompting the exploration of preventive strategies beyond conventional treatments. Cancer chemoprevention, which involves the use of natural or synthetic agents to impede, delay, or reverse car...
2025 | NEWPORT INTERNATIONAL JOURNAL OF PUBLIC HEALTH AND PHARMACY (NIJPP) | Pp. 11-15
Pediatric anemia remains a pervasive public health challenge in sub-Saharan Africa, particularly in Uganda and Nigeria, where it contributes significantly to child morbidity, cognitive delays, and mortality. Despite existing national interventions, the preval...
2025 | EURASIAN EXPERIMENT JOURNAL OF MEDICINE AND MEDICAL SCIENCES (EEJMMS) | Pp. 6-10
The HIV/AIDS epidemic in East Africa has been shaped by both devastating health impacts and remarkable progress achieved through global collaboration. This review examines the roles of the World Health Organization (WHO), the Joint United Nations Programme on...
2025 | NEWPORT INTERNATIONAL JOURNAL OF PUBLIC HEALTH AND PHARMACY (NIJPP) | Pp. 75-81
Artificial intelligence (AI) is transforming diabetes care across prevention, diagnosis, monitoring, and therapy personalization. Machine learning (ML), deep learning, and reinforcement learning approaches, combined with continuous glucose monitoring (CGM), c...
2025 | NEWPORT INTERNATIONAL JOURNAL OF CURRENT ISSUES IN ARTS AND MANAGEMENT (NIJCIAM) | Pp. 6-10
The rise of artificial intelligence (AI) is reshaping financial services globally, particularly in Sub-Saharan Africa, where financial exclusion remains a major challenge. This review explores how AI-powered mobile money services are driving financial inclusi...
2025 | EURASIAN EXPERIMENT JOURNAL OF MEDICINE AND MEDICAL SCIENCES (EEJMMS) | Pp. 11-17
Artemisinin-based combination therapies (ACTs) represent the cornerstone of contemporary falciparum malaria treatment worldwide. However, the emergence and spread of artemisinin-resistant Plasmodium falciparum strains pose significant threats to global malari...
2025 | EURASIAN EXPERIMENT JOURNAL OF MEDICINE AND MEDICAL SCIENCES (EEJMMS) | Pp. 18-28
Viral infections remain a major global health challenge, with limitations in conventional antiviral therapies including high costs, drug resistance, adverse side effects, and limited accessibility in resource-constrained regions. Beyond their established role...
2025 | NEWPORT INTERNATIONAL JOURNAL OF PUBLIC HEALTH AND PHARMACY (NIJPP) | Pp. 82-86
Antiretroviral therapy has transformed HIV from a fatal disease into a manageable chronic condition. However, metabolic complications, including insulin resistance, dyslipidemia, and type 2 diabetes mellitus (T2DM) have emerged as major concerns in long-term...
2025 | NEWPORT INTERNATIONAL JOURNAL OF PUBLIC HEALTH AND PHARMACY (NIJPP) | Pp. 99-103
Antioxidants are central to cellular defense against oxidative stress, a critical driver of obesity-associated carcinogenesis. Excess adiposity generates chronic inflammation, insulin resistance, and elevated production of reactive oxygen species, which contr...
2025 | EURASIAN EXPERIMENT JOURNAL OF MEDICINE AND MEDICAL SCIENCES | Pp. 29-38
Antimicrobial resistance (AMR) is a rapidly escalating global health crisis, driven by the misuse and overuse of antibiotics, poor regulation, and widespread self-medication. With resistant infections projected to cause up to 10 million deaths annually by 205...